102 related articles for article (PubMed ID: 21948491)
1. A patient with a metastatic gastroenteropancreatic endocrine carcinoma causing hyperinsulinaemic hypoglycaemia and the carcinoid syndrome.
Hinchliffe E; Allcock RL; Mansoor W; Myers MA
Ann Clin Biochem; 2011 Nov; 48(Pt 6):579-83. PubMed ID: 21948491
[TBL] [Abstract][Full Text] [Related]
2. A malignant cause of hypoglycaemia: a metastatic insulin-secreting pancreatic neuroendocrine carcinoma.
Sandoval MA; Pagsisihan D; Berberabe A; Palugod-Lopez EG
BMJ Case Rep; 2016 Mar; 2016():. PubMed ID: 26994053
[TBL] [Abstract][Full Text] [Related]
3. [Diagnostics and treatment in functional pancreatic neuroendocrine tumours].
Müssig K; Dudziak K; Horger M; Anlauf M; Goretzki PE
Dtsch Med Wochenschr; 2011 Jun; 136(24):1319-30. PubMed ID: 21656454
[TBL] [Abstract][Full Text] [Related]
4. [Treatment strategy of neuroendocrine tumors].
Ducreux M; Baudin E; Schlumberger M
Rev Prat; 2002 Feb; 52(3):290-6. PubMed ID: 11925720
[TBL] [Abstract][Full Text] [Related]
5. Insulinomatosis: a multicentric insulinoma disease that frequently causes early recurrent hyperinsulinemic hypoglycemia.
Anlauf M; Bauersfeld J; Raffel A; Koch CA; Henopp T; Alkatout I; Schmitt A; Weber A; Kruse ML; Braunstein S; Kaserer K; Brauckhoff M; Dralle H; Moch H; Heitz PU; Komminoth P; Knoefel WT; Perren A; Klöppel G
Am J Surg Pathol; 2009 Mar; 33(3):339-46. PubMed ID: 19011561
[TBL] [Abstract][Full Text] [Related]
6. [Pancreatic islet cell carcinoma with multiple hepatic metastases successfully treated with a streptozocin/5-FU regimen--a case report].
Arakawa Y; Mizunuma N; Aiba K; Ito Y; Takahashi S; Irie T; Watanabe J; Tada K; Okudaira T; Seki M; Yamaguchi T; Muto T; Hatake K
Gan To Kagaku Ryoho; 2002 Dec; 29(13):2561-4. PubMed ID: 12506483
[TBL] [Abstract][Full Text] [Related]
7. Interest of Chromogranin A for diagnosis and follow-up of endocrine tumours.
Nehar D; Lombard-Bohas C; Olivieri S; Claustrat B; Chayvialle JA; Penes MC; Sassolas G; Borson-Chazot F
Clin Endocrinol (Oxf); 2004 May; 60(5):644-52. PubMed ID: 15104570
[TBL] [Abstract][Full Text] [Related]
8. Insulinoma--a case report.
Dhume VM; Amarapurkar AD; Rege JD; Kandalkar BM; Varthakavi P
Indian J Pathol Microbiol; 2004 Oct; 47(4):540-1. PubMed ID: 16295390
[TBL] [Abstract][Full Text] [Related]
9. [The pathology of insulinoma and gastrinoma. The location, size, multicentricity, association with multiple endocrine type-I neoplasms and malignancy].
Donow C; Pipeleers-Marichal M; Stamm B; Heitz PU; Klöppel G
Dtsch Med Wochenschr; 1990 Sep; 115(37):1386-91. PubMed ID: 1976084
[TBL] [Abstract][Full Text] [Related]
10. Leucovorin and 5-fluorouracil as a treatment for disseminated cancer of the pancreas and unknown primary tumors.
Bruckner HW; Crown J; McKenna A; Hart R
Cancer Res; 1988 Oct; 48(19):5570-2. PubMed ID: 3046742
[TBL] [Abstract][Full Text] [Related]
11. FOLFOX-6 combination as the first-line treatment of locally advanced and/or metastatic pancreatic cancer.
Ghosn M; Farhat F; Kattan J; Younes F; Moukadem W; Nasr F; Chahine G
Am J Clin Oncol; 2007 Feb; 30(1):15-20. PubMed ID: 17278889
[TBL] [Abstract][Full Text] [Related]
12. Oxaliplatin, 5-fluorouracil, and leucovorin as second-line treatment for advanced pancreatic cancer.
Novarino A; Satolli MA; Chiappino I; Giacobino A; Bellone G; Rahimi F; Milanesi E; Bertetto O; Ciuffreda L
Am J Clin Oncol; 2009 Feb; 32(1):44-8. PubMed ID: 19194124
[TBL] [Abstract][Full Text] [Related]
13. A single-centre experience with octreotide in the treatment of different hypersecretory syndromes in patients with functional gastroenteropancreatic neuroendocrine tumors.
Berković MC; Altabas V; Herman D; Hrabar D; Goldoni V; Vizner B; Zjacić-Rotkvić V
Coll Antropol; 2007 Jun; 31(2):531-4. PubMed ID: 17847934
[TBL] [Abstract][Full Text] [Related]
14. [A case report of FOLFOX treatment for primary duodenal carcinoma with multiple liver metastases].
Fujiwara Y; Naomoto Y; Tanabe S; Sakurama K; Noma K; Nishikawa T; Motoki T; Takaoka M; Shirakawa Y; Yamatsuji T; Matsuoka J; Tanaka N
Gan To Kagaku Ryoho; 2009 Apr; 36(4):655-7. PubMed ID: 19381042
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic carcinoma with brain metastases: case report and literature review.
El Kamar FG; Jindal K; Grossbard ML; Mizrachi HH; Kozuch PS
Dig Liver Dis; 2004 May; 36(5):355-60. PubMed ID: 15191206
[TBL] [Abstract][Full Text] [Related]
16. [Dramatic efficacy of chemotherapy with 5-fluorouracil and dacarbazine in a patient with metastatic glucagonoma and cardiac insufficiency].
de Mestier L; Hammel P; Hentic O; Dove P; Lévy P; Ruszniewski P
Gastroenterol Clin Biol; 2010 Jan; 34(1):106-10. PubMed ID: 19875259
[TBL] [Abstract][Full Text] [Related]
17. Arterial infusion chemotherapy for the patient of unresectable pancreatic carcinoma with multiple liver metastases: a case report.
Fujii M; Miyake H; Sasaki K; Takagi T; Takamura K; Tashiro S
J Med Invest; 2003 Aug; 50(3-4):199-202. PubMed ID: 13678391
[TBL] [Abstract][Full Text] [Related]
18. [Clinico-biochemical findings in malignant carcinoid during cytostatic therapy (description of a case)].
Vyshinskaia GV; Bassalyk LS; Vasil'ev SA; Gromova NV; Nadezhdina TM
Ter Arkh; 1986; 58(2):129-31. PubMed ID: 3704929
[No Abstract] [Full Text] [Related]
19. Combination therapy with oxaliplatin and 5-fluorouracil in a patient with severe hepatic dysfunction associated with metastatic adenocarcinoma of the large bowel.
Grenader T; Goldberg A; Gabizon A
Anticancer Drugs; 2009 Oct; 20(9):845-7. PubMed ID: 19633535
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant treatment with weekly high-dose 5-fluorouracil as a 24h-infusion, folinic acid and biweekly oxaliplatin in patients with primary resectable liver metastases of colorectal cancer: long-term results of a phase II trial.
Boxberger F; Albrecht H; Konturek PC; Reulbach U; Maennlein G; Meyer T; Hohenberger W; Hahn EG; Wein A
Med Sci Monit; 2010 Feb; 16(2):CR49-55. PubMed ID: 20110914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
